Gur Pines

Oncology · 2012

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom Gur Pines trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. Baselga

Who trusts Gur Pines overall

  1. R. Roskoski

Papers from Gur Pines's perspective

Ordered by how strongly the researchers Gur Pines trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. (New England Journal of Medicine)
  2. Untangling the ErbB signalling network (Nature reviews. Molecular cell biology)
  3. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets (Nature Medicine)
  4. Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex. (Cancer Cell)
  5. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. (Cell)
  6. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab (Nature)
  7. Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth. (Cancer Cell)
  8. ERBB Receptors and Cancer: The Complexity of Targeted Inhibitors (Nature Reviews. Cancer)
  9. The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors. (Molecules and Cells)
  10. BRAF mutation predicts sensitivity to MEK inhibition (Nature)

Their papers